High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study

Y Arai¹, T Kondo¹, A Shigematsu², J Tanaka³, S Takahashi⁴, T Kobayashi⁵, N Uchida⁶, Y Onishi⁷, J Ishikawa⁸, H Kanamori⁹, M Sawa¹⁰, A Yokota¹¹, Y Kouzai¹², M Takanashi¹³, T Ichinohe¹⁴, Y Atsuta^{15

16}, S Mizuta¹⁷

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
³ Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
⁴ Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
⁵ Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
⁶ Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
⁷ Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
⁸ Department of Hematology and Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
⁹ Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
¹⁰ Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
¹¹ Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
¹² Department of Transfusion Medicine, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan.
¹³ Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
¹⁴ Department of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan.
¹⁵ Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
¹⁶ Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
¹⁷ Division of Hematology, Fujita Health University, Toyoake, Japan.

PMID: 27643870
DOI: 10.1038/bmt.2016.242

High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study

Y Arai et al. Bone Marrow Transplant. 2016 Dec.

. 2016 Dec;51(12):1636-1639.

doi: 10.1038/bmt.2016.242. Epub 2016 Sep 19.

Authors

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
³ Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
⁴ Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
⁵ Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
⁶ Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
⁷ Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
⁸ Department of Hematology and Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
⁹ Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
¹⁰ Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
¹¹ Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
¹² Department of Transfusion Medicine, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan.
¹³ Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
¹⁴ Department of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan.
¹⁵ Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
¹⁶ Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
¹⁷ Division of Hematology, Fujita Health University, Toyoake, Japan.

PMID: 27643870
DOI: 10.1038/bmt.2016.242

No abstract available

PubMed Disclaimer

References

1. Curr Hematol Malig Rep. 2013 Jun;8(2):141-8 - PubMed
1. Leukemia. 2012 Jul;26(7):1482-6 - PubMed
1. J Hematol Oncol. 2015 Sep 04;8:102 - PubMed
1. Blood. 2012 Nov 29;120(23):4470-81 - PubMed
1. J Clin Oncol. 2013 Apr 20;31(12):1530-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study

Affiliations

High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study

Authors

Affiliations

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources